Clinical Trials Browser

Phase 1 × Uveal Melanoma × siremadlin × Clear all

NCT02601378 2022-09-29

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

Phase 1 Terminated

Uveal Melanoma